SeaSpine to Report First Quarter 2018 Financial Results on May 3, 2018
April 19 2018 - 4:30PM
SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical
technology company focused on surgical solutions for the treatment
of spinal disorders, announced today that it will release first
quarter 2018 financial results after the close of trading on
Thursday, May 3, 2018. The Company's management team will host a
conference call beginning at 1:30pm PT / 4:30pm ET to discuss the
financial results and recent business developments.
Individuals interested in listening to the
conference call may do so by dialing (877) 418-4766 for domestic
callers or (614) 385-1253 for international callers, using
Conference ID: 8167947. To listen to a live webcast, please visit
the Investors section of the SeaSpine website at:
www.seaspine.com.
The call will be archived until Thursday May 17,
2018. The audio archive can be accessed by calling (855) 859-2056
in the U.S. or (404) 537-3406 from outside the U.S. The passcode
for the audio replay is 8167947.
About SeaSpine
SeaSpine is a global medical technology company
focused on the design, development and commercialization of
surgical solutions for the treatment of patients suffering from
spinal disorders. SeaSpine has a comprehensive portfolio of
orthobiologics and spinal implants solutions to meet the varying
combinations of products that neurosurgeons and orthopedic spine
surgeons need to perform fusion procedures on the lumbar, thoracic
and cervical spine. SeaSpine’s orthobiologics products consist of a
broad range of advanced and traditional bone graft substitutes that
are designed to improve bone fusion rates following a wide range of
orthopedic surgeries, including spine, hip, and extremities
procedures. SeaSpine’s spinal implants portfolio consists of an
extensive line of products to facilitate spinal fusion in minimally
invasive surgery, complex spine, deformity and degenerative
procedures. Expertise in both orthobiologic sciences and spinal
implants product development allows SeaSpine to offer its surgeon
customers a differentiated portfolio and a complete procedural
solution to meet their fusion requirements. SeaSpine currently
markets its products in the United States and in over 30 countries
worldwide.
Investor Relations Contact Lynn Pieper (415)
937-5402ir@seaspine.com
SeaSpine (NASDAQ:SPNE)
Historical Stock Chart
From Mar 2024 to Apr 2024
SeaSpine (NASDAQ:SPNE)
Historical Stock Chart
From Apr 2023 to Apr 2024